ibd pam w20062798 6 important notice important notice
play

IBD\Pam\W20062798.6 Important notice Important notice By attending - PDF document

IBD\Pam\W20062798.6 Important notice Important notice By attending the meeting where this roadshow presentation is made, you agree to be bound by the following limitations. This document has been prepared by PEGAS NONWOVENS SA (the Company )


  1. IBD\Pam\W20062798.6

  2. Important notice Important notice By attending the meeting where this roadshow presentation is made, you agree to be bound by the following limitations. This document has been prepared by PEGAS NONWOVENS SA (the Company ) solely for use by you at the presentation, held in connection with the proposed offering and sale of shares of the Company (the Offering ). The information contained in this document has not been independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. The information set out herein may be subject to updating, revision, verification and amendment and such information may change materially. The Company is under no obligation to update or keep current the information contained in this document or in the presentation to which it relates and any opinions expressed in them is subject to change without notice. None of the Company or any of its respective affiliates, advisers or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this document or its contents, or otherwise arising in connection with this presentation. This presentation is being communicated in the United Kingdom only to persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Order ) and to persons to whom it may otherwise be lawful to communicate it to (all such persons being referred to as relevant persons ). This presentation is only directed at relevant persons and any investment or investment activity to which the presentation relates is only available to relevant persons or will be engaged in only with relevant persons. Solicitations resulting from this presentation will only be responded to if the person concerned is a relevant person. Other persons should not rely or act upon this presentation or any of its contents. The information in this presentation is given in confidence and may not be reproduced or redistributed to any other persons. The recipients of this presentation should not base any behaviour in relation to qualifying investments or relevant products (as defined in the Financial Services and Markets Act 2000 ( FSMA ) and the Code of Market Conduct made pursuant to FSMA) which would amount to market abuse for the purposes of FSMA on the information in this presentation until after the information has been made generally available. Nor should the recipient use the information in this presentation in any way which would constitute 'market abuse'. This presentation is an advertisement and does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities of the Company nor should it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever. Any decision to purchase or subscribe for securities in connection with the Offering should be made solely on the basis of the information contained in the prospectus in relation to the Offering, which was published on December 4, 2006 and is available at the following internet addresses: www.pegas.lu and www.pegas.cz. This presentation does not constitute a recommendation regarding the securities of the Company. This presentation and the information contained herein are not an offer of securities for sale in the United States and are not for publication or distribution to persons in the United States (within the meaning of Regulation S under the United States Securities Act of 1933, as amended (the Securities Act )). The securities proposed to be offered in the Company have not been and will not be registered under the Securities Act and may not be offered or sold in the United States except pursuant to an exemption from, or transaction not subject to, the registration requirements of the Securities Act. Certain statements in this presentation, including those related to the Offering and the admission of the shares in the Company to trading on the Prague Stock Exchange and the Warsaw Stock Exchange ( Admission ), constitute 'forward-looking statements'. These statements, which contain the words 'anticipate', 'believe', 'intend', 'estimate', 'expect' and words of similar meaning, reflect the Directors' beliefs and expectations and are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, securing necessary governmental and other approvals, the satisfaction of the conditions of the Offering, changing business or other market conditions and the prospects for growth anticipated by the management of the Company. These and other factors could adversely affect the outcome and financial effects of the plans and events described herein. As a result, you are cautioned not to place undue reliance on such forward- looking statements. The Company and its directors disclaim any obligation to update their view of such risks and uncertainties or to publicly announce the result of any revisions to the forward-looking statements made herein, except where it would be required to do so under applicable law. ING is acting for the Company and no-one else in connection with the Admission and the Offering and will not be responsible to any other person for providing the protections afforded to their respective clients, or for providing advice in relation to Admission and the Offering. IBD\Pam\W20062798.6 every single detail Page 1 December 2006

  3. Introduction and the offering Introduction and the offering IBD\Pam\W20062798.6 every single detail Page 2 December 2006

  4. Presentation team Presentation team Mr Milos Bogdan Chief Executive Officer Mr Ales Gerza Financial Director Mr Frantisek Klaska Technical Director Mr Frantisek Rezac Commercial Director Mr Henry Gregson Non-executive Director IBD\Pam\W20062798.6 every single detail Page 3 December 2006

  5. Offering details Offering details The Issuer PEGAS NONWOVENS SA • Selling Shareholder PEGAS NONWOVENS SA, Pamplona Capital Partners I, LP • Offer size Up to EUR124m (base deal), EUR143m (post-greenshoe) • Offer structure Up to 4,595,000 shares, consisting of primary and secondary shares • Indicative price guidance EUR21.50 to EUR27.00 per share • Greenshoe 15% of the Base Deal (689,250 shares, all secondary) • Free float Up to 57% post-greenshoe (50% pre-greenshoe) • Expected market capitalisation EUR250m post-money (at the top of the indicative price guidance range) • Lock up 180 days on pre-IPO shareholders and the Company • Listing Prague Stock Exchange and Warsaw Stock Exchange • IBD\Pam\W20062798.6 every single detail Page 4 December 2006

  6. Timeline Timeline Roadshow 5 December 2006 to 14 December 2006 • Books open 5 December • Books close 14 December (18:00 CET Prague & Warsaw, 17:00 GMT London) • Pricing & Allotment 15 December 2006 • Settlement (T+2) 19 December 2006 • Listing On or about 21 December (PSE and WSE) • Syndicate Global Co-ordinator and ING • Bookrunner Co-lead Manager Ceska sporitelna • Selling agent Patria • IBD\Pam\W20062798.6 every single detail Page 5 December 2006

  7. An excellent investment opportunity An excellent investment opportunity Growing market Sales growth Imminent new capacity Demand not cyclical or seasonal Focus on high-margin specialty products Low cost base High Margins Tax incentives Low scrap rates High barriers to entry Protected Margins Polymer pass-through BBA ‘Price Floor’ IBD\Pam\W20062798.6 every single detail Page 6 December 2006

  8. Company overview Company overview IBD\Pam\W20062798.6 every single detail Page 7 December 2006

  9. Market leader in 'spunmelt' nonwovens Market leader in 'spunmelt' nonwovens Overview Cost advantage and growth track record • PEGAS manufactures a range of non-woven textiles, mainly • Favourable location ensures a low-cost base and good in 'spunmelt' – the superior and winning technology access to major customers across Europe • Europe’s second largest manufacturer of PP and PP/PE- • Strong growth (CAGR): based 'hygiene' nonwovens in volume terms - capacity growth – 31.0% p.a. (1995-2007E) - 19% share of European hygiene market - sales growth – 27.5% p.a. (2003-2005) - almost 90% products exported - EBITDA growth – 24.1% p.a. (2003-2005) - 11% market share in Europe (by capacity installed) - 2005/2004 y-o-y production growth of 38% - newest equipment in Europe - most advanced equipment in Europe • Production output of c.51,300 tonnes (net of scrap, 2005) - c.90% for personal hygiene industry (market worth EUR1.4bn p.a.) which is fast growing in the CEE and Russia - c.10% for construction, agricultural and medical applications • Europe’s only manufacturer of high-margin, bi-component ('BiCo') spunmelt products for the hygiene industry • Leading-edge technology and know-how, difficult to replicate by competitors IBD\Pam\W20062798.6 every single detail Page 8 December 2006

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend